| NCT ID | NCT01558544 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 1997-04 |
| Primary Completion | 2029-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 1997-04 with a primary completion date of 2029-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.
Eligibility Criteria
Inclusion Criteria: * Females 0-45 years of age who are premenopausal * Treatment plan that will likely result in premature menopause or premature ovarian failure * This includes patients receiving: * Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy * Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients * Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos. * Previous treatment for cancer is acceptable if patient still has ovarian function * Patient is medically stable enough to undergo surgery (cleared for anesthesia) Exclusion Criteria: * Patients not meeting the above criteria * Patients who have not received medical clearance from their physicians to undergo surgery * Patients already experiencing menopause.
Contact & Investigator
Glenn Schattman, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT01558544 clinical trial?
This trial is open to female participants only, up to 45 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01558544 currently recruiting?
Yes, NCT01558544 is actively recruiting participants. Contact the research team at res2011@med.cornell.edu for enrollment information.
Where is the NCT01558544 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT01558544 clinical trial?
NCT01558544 is sponsored by Weill Medical College of Cornell University. The principal investigator is Glenn Schattman, MD at Weill Medical College of Cornell University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.